Advocacy at a Glance STEVEN GROSSMAN 4/21/17 Advocacy at a Glance STEVEN GROSSMAN 4/21/17 Alliance Hill Day Read More Analysis and Commentary STEVEN GROSSMAN 4/21/17 Analysis and Commentary STEVEN GROSSMAN 4/21/17 Now Is the Time for YOU to Take Action, PLEASE Read More Advocacy at a Glance STEVEN GROSSMAN 3/31/17 Advocacy at a Glance STEVEN GROSSMAN 3/31/17 The FY17 Continuing Resolution Expires Soon and more Read More Analysis and Commentary STEVEN GROSSMAN 2/3/17 Analysis and Commentary STEVEN GROSSMAN 2/3/17 One Size Still Does Not Fit All Read More Advocacy at a Glance STEVEN GROSSMAN 1/19/17 Advocacy at a Glance STEVEN GROSSMAN 1/19/17 Prepping for the New Congress: Macro- and Micro-Budget Considerations for FDA and more Read More Advocacy at a Glance STEVEN GROSSMAN 6/25/16 Advocacy at a Glance STEVEN GROSSMAN 6/25/16 Congressional Calendar Leaves Little Time for Legislating Read More Advocacy at a Glance STEVEN GROSSMAN 4/30/16 Advocacy at a Glance STEVEN GROSSMAN 4/30/16 Senate and House in Recess Next Week Read More Advocacy at a Glance STEVEN GROSSMAN 3/12/16 Advocacy at a Glance STEVEN GROSSMAN 3/12/16 FDA to Apply Lean Management Tools to Handling of Combination Products and more Read More Advocacy at a Glance STEVEN GROSSMAN 11/16/15 Advocacy at a Glance STEVEN GROSSMAN 11/16/15 Not Too Late to Write Appropriators to Increase FY 16 Funding for the FDA and more Read More Advocacy at a Glance STEVEN GROSSMAN 11/6/15 Advocacy at a Glance STEVEN GROSSMAN 11/6/15 Please Send Us Your Letter in Support of FDA Funding and more Read More
Advocacy at a Glance STEVEN GROSSMAN 4/21/17 Advocacy at a Glance STEVEN GROSSMAN 4/21/17 Alliance Hill Day Read More
Analysis and Commentary STEVEN GROSSMAN 4/21/17 Analysis and Commentary STEVEN GROSSMAN 4/21/17 Now Is the Time for YOU to Take Action, PLEASE Read More
Advocacy at a Glance STEVEN GROSSMAN 3/31/17 Advocacy at a Glance STEVEN GROSSMAN 3/31/17 The FY17 Continuing Resolution Expires Soon and more Read More
Analysis and Commentary STEVEN GROSSMAN 2/3/17 Analysis and Commentary STEVEN GROSSMAN 2/3/17 One Size Still Does Not Fit All Read More
Advocacy at a Glance STEVEN GROSSMAN 1/19/17 Advocacy at a Glance STEVEN GROSSMAN 1/19/17 Prepping for the New Congress: Macro- and Micro-Budget Considerations for FDA and more Read More
Advocacy at a Glance STEVEN GROSSMAN 6/25/16 Advocacy at a Glance STEVEN GROSSMAN 6/25/16 Congressional Calendar Leaves Little Time for Legislating Read More
Advocacy at a Glance STEVEN GROSSMAN 4/30/16 Advocacy at a Glance STEVEN GROSSMAN 4/30/16 Senate and House in Recess Next Week Read More
Advocacy at a Glance STEVEN GROSSMAN 3/12/16 Advocacy at a Glance STEVEN GROSSMAN 3/12/16 FDA to Apply Lean Management Tools to Handling of Combination Products and more Read More
Advocacy at a Glance STEVEN GROSSMAN 11/16/15 Advocacy at a Glance STEVEN GROSSMAN 11/16/15 Not Too Late to Write Appropriators to Increase FY 16 Funding for the FDA and more Read More
Advocacy at a Glance STEVEN GROSSMAN 11/6/15 Advocacy at a Glance STEVEN GROSSMAN 11/6/15 Please Send Us Your Letter in Support of FDA Funding and more Read More
